Inactive Instrument

Analyst Reco. Essity AB Other OTC

Equities

ESSITY : Q1 24: Strong margin delivery despite soft volumes	05-03
ESSITY : Multiple silver linings although the headline Q4 23 disappoints	01-25
ESSITY : EPS cut (2023: +15.3%, 2024: -16.9%)	01-22
ESSITY : Q3 23: Falling input costs should sustain strong margin traction	11-02
ESSITY : Essity Q2 23: Unwarranted sell-off, margin recovery clearly intact	23-07-21
ESSITY : Strong Q1 23 underpinned by broad-based momentum	23-04-27
ESSITY : Q4 22: Past a margin trough?	23-01-27
ESSITY : Low price elasticity makes up for weak Q3 22 earnings	22-11-02
ESSITY : Q2 21: the beat isn’t good enough...	22-07-22
ESSITY : Q1 22: Pricing execution stands out in face of cost headwinds	22-04-23
China, rate hike worries push European stocks to 1-month closing low	22-04-22	RE
ESSITY : Q4/FY 21: input inflation offsets top-line momentum	22-01-31
ESSITY : Q3 21: Broadening cost inflation will require more price increases	21-10-25
ANALYST RECOMMENDATIONS : GlaxoSmithKline, Qualcomm, State Street, Tate & Lyle, Virgin Money UK...	21-07-19
ESSITY : Q2 21: steep margin headwinds	21-07-16
Exane BNP Paribas European CEO Conference	21-06-07	FA
Berenberg US Conference	21-05-17	FA
ESSITY : Q1 21 miss precedes margin challenges	21-04-23
Index overview : A bond index and the Rolls Royce of European indices	21-04-01
ESSITY : FY 20: professional hygiene, the ‘wildcard’	21-02-05

No results for this search

ESSITY : Q1 24: Strong margin delivery despite soft volumes

May 03, 2024 at 01:50 pm